{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"ss-31-frozen-shoulder","title":"SS-31 (Elamipretide) for Frozen Shoulder: Mitochondrial Evidence Review","body":"## What's breaking down if you have Frozen shoulder\n\nFrozen shoulder, also called adhesive capsulitis, involves the shoulder joint capsule becoming inflamed and thickened. Adhesions form inside the capsule. This leads to progressive stiffness and pain that limits range of motion.\n\nThe condition often develops in stages. An initial painful phase features inflammation. A freezing phase brings increasing stiffness. A frozen phase shows restricted movement with less pain. A thawing phase sees gradual improvement over months to years.\n\nDegeneration layers include chronic low-grade inflammation, excessive collagen deposition causing fibrosis, reduced blood flow to the capsule, and possible mitochondrial stress in shoulder muscles and connective tissue cells. If mitochondrial function declines, cells produce less ATP and more reactive oxygen species. This can slow tissue repair and prolong the inflammatory state. The capsule and surrounding muscles then stay in a cycle where breakdown outruns natural repair.\n\nNo weight-loss drugs appear in scope here. Mechanical load reduction is not a primary factor for the shoulder in the same way it is for the spine, though overall inflammation reduction could indirectly ease joint stress.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about **Frozen shoulder** — what breaks down matters before any compound name.\n2. **Therefore for you:** If mitochondrial dysfunction is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\n\nSS-31 binds to cardiolipin in the inner mitochondrial membrane. This stabilizes the membrane, reduces excess reactive oxygen species, and supports ATP production. In a shoulder capsule or muscle cell under inflammatory stress, better mitochondrial output could supply energy for repair processes instead of letting oxidative damage accumulate.\n\nIf your frozen shoulder shows persistent inflammation or slow healing after months, the mitochondrial layer may contribute. SS-31 focuses on that layer by protecting mitochondria rather than broadly suppressing immune signals or numbing nerves.\n\n## How these fit together\n\nSingle-compound focus. SS-31 (Elamipretide) targets the mitochondrial layer. If your condition profile includes a multi-peptide stack in other contexts, siblings would address other layers such as direct anti-fibrotic or vascular support. Here the emphasis stays on mitochondrial bioenergetics as one potential repair pathway.\n\n## What the evidence actually shows\n\nNo published human trials test SS-31 specifically in frozen shoulder or adhesive capsulitis (preclinical tier for condition match). Clinical trials of SS-31 exist in other mitochondrial or inflammatory conditions.\n\nPreclinical studies show SS-31 protects cartilage after impact injury in bovine knee models and reduces osteoarthritis symptoms in guinea pig models via radiographic and histologic scores (preclinical). One murine tendinopathy model examined SS-31 in supraspinatus tendon (preclinical). Neuroinflammation and kidney injury models demonstrate reduced oxidative stress and preserved ATP (preclinical).\n\nHuman data come from trials in primary mitochondrial myopathy, heart failure, and Barth syndrome. A phase 1/2 trial in primary mitochondrial myopathy reported dose-dependent exercise improvements (human). Barth syndrome received FDA approval in 2025 based on functional gains (human). No shoulder-specific outcomes appear in those trials.\n\nAnecdotal reports on forums mention SS-31 use for general energy or other joint issues but lack controlled data on frozen shoulder resolution (anecdotal).\n\n## What scientists say\n\nResearchers describe SS-31 as a mitochondria-targeted tetrapeptide that improves bioenergetics without affecting healthy mitochondria. Publications note benefits in models of oxidative stress and fibrosis (mechanistic). They emphasize the need for more targeted human studies in musculoskeletal conditions (speculative for frozen shoulder).\n\n## What people say on Reddit\n\nForum users discuss SS-31 in broader peptide stacks for recovery or energy. Isolated mentions link other peptides to frozen shoulder improvement. Direct SS-31 experiences for this condition remain rare and uncontrolled (anecdotal). Some report subjective energy gains; others note no clear change or mild side effects.\n\n## What people say on X\n\nPosts reference SS-31 clinical progress in heart failure and mitochondrial disorders. One user with a shoulder injury mentioned ongoing SS-31 use alongside other approaches but provided no outcome details (anecdotal). Discussions focus on mitochondrial support in low-vascular tissues rather than frozen shoulder specifically.\n\n## What we do not know\n\nDirect evidence linking SS-31 to frozen shoulder capsule repair or symptom resolution is absent. Human trials have not measured shoulder range of motion, pain scores, or imaging changes with this peptide. Long-term effects on fibrosis or adhesions remain unstudied. Optimal timing relative to disease stage is unknown.\n\n## Safety and limits\n\nIn published trials, SS-31 was generally well tolerated. Common reports include mild injection site reactions. Serious adverse events appear infrequent across mitochondrial disease studies (human). It remains investigational outside approved rare-disease uses. Quality and sourcing vary widely for non-clinical material. No data confirm safety or efficacy when combined with physical therapy or other interventions for frozen shoulder.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/ss-31-frozen-shoulder/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No published human trials test SS-31 in frozen shoulder or adhesive capsulitis.","section":"What the evidence actually shows","tier":"preclinical","source_ids":[],"source_status":"unsourced","why_material":"Establishes the direct evidence gap for this specific condition.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"SS-31 protects bovine knee cartilage from impact injury in ex vivo models.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["web:16"],"source_status":"sourced","why_material":"Shows mitochondrial protection in joint tissue relevant to shoulder capsule stress.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"SS-31 reduced osteoarthritis symptoms in guinea pig models per radiographic and histologic scores.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["web:17"],"source_status":"sourced","why_material":"Demonstrates anti-degenerative effects in a joint model.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Phase 1/2 human trial of SS-31 in primary mitochondrial myopathy showed dose-dependent exercise improvements.","section":"What the evidence actually shows","tier":"human","source_ids":["web:11"],"source_status":"sourced","why_material":"Provides the strongest human functional data available.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"SS-31 received FDA approval for Barth syndrome in 2025 based on functional gains.","section":"What the evidence actually shows","tier":"human","source_ids":["web:3"],"source_status":"sourced","why_material":"Confirms regulatory recognition of mitochondrial benefit in a rare disease.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c6","text":"SS-31 binds cardiolipin to stabilize mitochondria and reduce ROS while supporting ATP.","section":"Why SS-31 (Elamipretide) might help you","tier":"mechanistic","source_ids":["web:14"],"source_status":"sourced","why_material":"Explains the repair-focused mechanism for the mitochondrial layer.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"web:3","type":"news","url":"https://www.fightaging.org/archives/2025/10/fda-approval-for-mitochondrial-therapeutic-elamipretide-formerly-ss-31/","title":"FDA Approval for Mitochondrial Therapeutic Elamipretide, Formerly SS-31","quote":"The recent FDA approval of elamipretide is for the treatment of a rare disease...","summary":"Reports 2025 FDA approval for Barth syndrome.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:56:01.675Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"0347420b479319c80d3046ab78579e86ccc25f867916838abcd8e95027a8e166"},{"id":"web:11","type":"pubmed","url":"https://www.neurology.org/doi/10.1212/WNL.0000000000005255","title":"Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy","quote":"a dose-dependent improvement in exercise performance was observed","summary":"Human trial results in PMM.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:56:01.675Z","link_status":"ok","quote_status":"unverified","prev":"0347420b479319c80d3046ab78579e86ccc25f867916838abcd8e95027a8e166","hash":"6451b9ec4e68274e0b9d7e1f25f7c1fd01ab8581432d39c0a444eb8d82dc91cf"},{"id":"web:16","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/SS-31-Cognitive-Vitality-For-Researchers.pdf","title":"SS-31 Cognitive Vitality For Researchers","quote":"SS-31 treatment immediately post-impact... resulted in chondrocyte viability similar to that of uninjured controls","summary":"Preclinical cartilage protection data.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:56:01.675Z","link_status":"ok","quote_status":"unverified","prev":"6451b9ec4e68274e0b9d7e1f25f7c1fd01ab8581432d39c0a444eb8d82dc91cf","hash":"ff6b364eae5703d46dcb507197ee42ee9bf09a28ab40ea445274f0f5d7835e71"},{"id":"web:17","type":"other","url":"https://www.ors.org/wp-content/uploads/AM24/2529.pdf","title":"Therapeutic Efficacy of mitoprotective SS-31 peptide in Osteoarthritis","quote":"significant reduction in cartilage damage and OA symptoms","summary":"Guinea pig OA model results.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:56:01.675Z","link_status":"ok","quote_status":"unverified","prev":"ff6b364eae5703d46dcb507197ee42ee9bf09a28ab40ea445274f0f5d7835e71","hash":"2740d9b97993e514ca54dd140fce8c8cf317c8b806b8cf52c5b4a282afba304e"},{"id":"web:14","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9192202/","title":"SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Injury","quote":"SS-31... decreases mitochondrial reactive oxygen species production and prevents mitochondrial depolarization","summary":"Mechanism details on ROS and mitochondria.","claim_ids":["c6"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:56:01.675Z","link_status":"ok","quote_status":"unverified","prev":"2740d9b97993e514ca54dd140fce8c8cf317c8b806b8cf52c5b4a282afba304e","hash":"7ebc2b63807ec666e1483243b0abbfdbb2eae2b28b7eac50011b2ffd61f3dfeb"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:56:02.397Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"SS-31 (Elamipretide) for Frozen Shoulder: Mitochondrial Evidence Review","register":"source_ledger","body":"## What's breaking down if you have Frozen shoulder\n\nFrozen shoulder, also called adhesive capsulitis, involves the shoulder joint capsule becoming inflamed and thickened. Adhesions form inside the capsule. This leads to progressive stiffness and pain that limits range of motion.\n\nThe condition often develops in stages. An initial painful phase features inflammation. A freezing phase brings increasing stiffness. A frozen phase shows restricted movement with less pain. A thawing phase sees gradual improvement over months to years.\n\nDegeneration layers include chronic low-grade inflammation, excessive collagen deposition causing fibrosis, reduced blood flow to the capsule, and possible mitochondrial stress in shoulder muscles and connective tissue cells. If mitochondrial function declines, cells produce less ATP and more reactive oxygen species. This can slow tissue repair and prolong the inflammatory state. The capsule and surrounding muscles then stay in a cycle where breakdown outruns natural repair.\n\nNo weight-loss drugs appear in scope here. Mechanical load reduction is not a primary factor for the shoulder in the same way it is for the spine, though overall inflammation reduction could indirectly ease joint stress.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about **Frozen shoulder** — what breaks down matters before any compound name.\n2. **Therefore for you:** If mitochondrial dysfunction is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\n\nSS-31 binds to cardiolipin in the inner mitochondrial membrane. This stabilizes the membrane, reduces excess reactive oxygen species, and supports ATP production. In a shoulder capsule or muscle cell under inflammatory stress, better mitochondrial output could supply energy for repair processes instead of letting oxidative damage accumulate.\n\nIf your frozen shoulder shows persistent inflammation or slow healing after months, the mitochondrial layer may contribute. SS-31 focuses on that layer by protecting mitochondria rather than broadly suppressing immune signals or numbing nerves.\n\n## How these fit together\n\nSingle-compound focus. SS-31 (Elamipretide) targets the mitochondrial layer. If your condition profile includes a multi-peptide stack in other contexts, siblings would address other layers such as direct anti-fibrotic or vascular support. Here the emphasis stays on mitochondrial bioenergetics as one potential repair pathway.\n\n## What the evidence actually shows\n\nNo published human trials test SS-31 specifically in frozen shoulder or adhesive capsulitis (preclinical tier for condition match). Clinical trials of SS-31 exist in other mitochondrial or inflammatory conditions.\n\nPreclinical studies show SS-31 protects cartilage after impact injury in bovine knee models and reduces osteoarthritis symptoms in guinea pig models via radiographic and histologic scores (preclinical). One murine tendinopathy model examined SS-31 in supraspinatus tendon (preclinical). Neuroinflammation and kidney injury models demonstrate reduced oxidative stress and preserved ATP (preclinical).\n\nHuman data come from trials in primary mitochondrial myopathy, heart failure, and Barth syndrome. A phase 1/2 trial in primary mitochondrial myopathy reported dose-dependent exercise improvements (human). Barth syndrome received FDA approval in 2025 based on functional gains (human). No shoulder-specific outcomes appear in those trials.\n\nAnecdotal reports on forums mention SS-31 use for general energy or other joint issues but lack controlled data on frozen shoulder resolution (anecdotal).\n\n## What scientists say\n\nResearchers describe SS-31 as a mitochondria-targeted tetrapeptide that improves bioenergetics without affecting healthy mitochondria. Publications note benefits in models of oxidative stress and fibrosis (mechanistic). They emphasize the need for more targeted human studies in musculoskeletal conditions (speculative for frozen shoulder).\n\n## What people say on Reddit\n\nForum users discuss SS-31 in broader peptide stacks for recovery or energy. Isolated mentions link other peptides to frozen shoulder improvement. Direct SS-31 experiences for this condition remain rare and uncontrolled (anecdotal). Some report subjective energy gains; others note no clear change or mild side effects.\n\n## What people say on X\n\nPosts reference SS-31 clinical progress in heart failure and mitochondrial disorders. One user with a shoulder injury mentioned ongoing SS-31 use alongside other approaches but provided no outcome details (anecdotal). Discussions focus on mitochondrial support in low-vascular tissues rather than frozen shoulder specifically.\n\n## What we do not know\n\nDirect evidence linking SS-31 to frozen shoulder capsule repair or symptom resolution is absent. Human trials have not measured shoulder range of motion, pain scores, or imaging changes with this peptide. Long-term effects on fibrosis or adhesions remain unstudied. Optimal timing relative to disease stage is unknown.\n\n## Safety and limits\n\nIn published trials, SS-31 was generally well tolerated. Common reports include mild injection site reactions. Serious adverse events appear infrequent across mitochondrial disease studies (human). It remains investigational outside approved rare-disease uses. Quality and sourcing vary widely for non-clinical material. No data confirm safety or efficacy when combined with physical therapy or other interventions for frozen shoulder.","claims":[{"id":"c1","text":"No published human trials test SS-31 in frozen shoulder or adhesive capsulitis.","section":"What the evidence actually shows","tier":"preclinical","source_ids":[],"source_status":"unsourced","why_material":"Establishes the direct evidence gap for this specific condition.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"SS-31 protects bovine knee cartilage from impact injury in ex vivo models.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["web:16"],"source_status":"sourced","why_material":"Shows mitochondrial protection in joint tissue relevant to shoulder capsule stress.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"SS-31 reduced osteoarthritis symptoms in guinea pig models per radiographic and histologic scores.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["web:17"],"source_status":"sourced","why_material":"Demonstrates anti-degenerative effects in a joint model.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Phase 1/2 human trial of SS-31 in primary mitochondrial myopathy showed dose-dependent exercise improvements.","section":"What the evidence actually shows","tier":"human","source_ids":["web:11"],"source_status":"sourced","why_material":"Provides the strongest human functional data available.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"SS-31 received FDA approval for Barth syndrome in 2025 based on functional gains.","section":"What the evidence actually shows","tier":"human","source_ids":["web:3"],"source_status":"sourced","why_material":"Confirms regulatory recognition of mitochondrial benefit in a rare disease.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c6","text":"SS-31 binds cardiolipin to stabilize mitochondria and reduce ROS while supporting ATP.","section":"Why SS-31 (Elamipretide) might help you","tier":"mechanistic","source_ids":["web:14"],"source_status":"sourced","why_material":"Explains the repair-focused mechanism for the mitochondrial layer.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"web:3","type":"news","url":"https://www.fightaging.org/archives/2025/10/fda-approval-for-mitochondrial-therapeutic-elamipretide-formerly-ss-31/","title":"FDA Approval for Mitochondrial Therapeutic Elamipretide, Formerly SS-31","quote":"The recent FDA approval of elamipretide is for the treatment of a rare disease...","link_status":"ok","quote_status":"unverified"},{"id":"web:11","type":"pubmed","url":"https://www.neurology.org/doi/10.1212/WNL.0000000000005255","title":"Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy","quote":"a dose-dependent improvement in exercise performance was observed","link_status":"ok","quote_status":"unverified"},{"id":"web:16","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/SS-31-Cognitive-Vitality-For-Researchers.pdf","title":"SS-31 Cognitive Vitality For Researchers","quote":"SS-31 treatment immediately post-impact... resulted in chondrocyte viability similar to that of uninjured controls","link_status":"ok","quote_status":"unverified"},{"id":"web:17","type":"other","url":"https://www.ors.org/wp-content/uploads/AM24/2529.pdf","title":"Therapeutic Efficacy of mitoprotective SS-31 peptide in Osteoarthritis","quote":"significant reduction in cartilage damage and OA symptoms","link_status":"ok","quote_status":"unverified"},{"id":"web:14","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9192202/","title":"SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Injury","quote":"SS-31... decreases mitochondrial reactive oxygen species production and prevents mitochondrial depolarization","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":27620,"tokens_out":3695,"cost":0.0437625,"prev_hash":"genesis","hash":"072b4be2a30b7750b29530bc6555c25d193b80302f9f411598f47278121f0a24"}],"provenance":[{"ts":"2026-06-29T23:56:02.397Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Ss 31 for Frozen Shoulder\nSlug: ss-31-frozen-shoulder\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Frozen shoulder\",\"condition_key\":\"frozen-shoulder\",\"primary_peptide\":\"ss-31\",\"peptides_in_scope\":[{\"id\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\"}],\"drugs_in_scope\":[],\"weight_sensitive\":true,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Frozen shoulder\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\",\"section_title\":\"Why SS-31 (Elamipretide) might help you\",\"layer\":\"mitochondrial\",\"steps\":[\"You are reading about **Frozen shoulder** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Frozen shoulder** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **SS-31 (Elamipretide)** → mitochondrial\",\"section_headings\":[\"What's breaking down if you have Frozen shoulder\",","response":"{\n  \"slug\": \"ss-31-frozen-shoulder\",\n  \"title\": \"SS-31 (Elamipretide) for Frozen Shoulder: Mitochondrial Evidence Review\",\n  \"body\": \"## What's breaking down if you have Frozen shoulder\\n\\nFrozen shoulder, also called adhesive capsulitis, involves the shoulder joint capsule becoming inflamed and thickened. Adhesions form inside the capsule. This leads to progressive stiffness and pain that limits range of motion.\\n\\nThe condition often develops in stages. An initial painful phase features inflammation. A freezing phase brings increasing stiffness. A frozen phase shows restricted movement with less pain. A thawing phase sees gradual improvement over months to years.\\n\\nDegeneration layers include chronic low-grade inflammation, excessive collagen deposition causing fibrosis, reduced blood flow to the capsule, and possible mitochondrial stress in shoulder muscles and connective tissue cells. If mitochondrial function declines, cells produce less ATP and more reactive oxygen species. This can slow tissue repair and prolong the inflammatory state. The capsule and surrounding muscles then stay in a cycle where breakdown outruns natural repair.\\n\\nNo weight-loss drugs appear in scope here. Mechanical load reduction is not a primary factor for the shoulder in the same way it is for the spine, though overall inflammation reduction could indirectly ease joint stress.\\n\\n## Why SS-31 (Elamipretide) might help you\\n\\n1. You are reading about **Frozen shoulder** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If mitochondrial dysfunction is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nSS-31 binds to cardiolipin in the inner mitochondrial membrane. This stabilizes the membrane, reduces excess reactive oxygen species, and supports ATP production. In a shoulder capsule or muscle cell under inflammatory stress, better mitochondrial output could supply energy for repair proc","tokens_in":27620,"tokens_out":3695,"cost":0,"prev":"genesis","hash":"d8e93df3e14938152ea079fb8b6c3a4629605ffd5cccac963e0288eeecd8bed9"},{"ts":"2026-07-17T02:42:02.778Z","model":"owner","action":"voxel_divide","prompt":"","input":"ss-31-frozen-shoulder","response":"26 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d8e93df3e14938152ea079fb8b6c3a4629605ffd5cccac963e0288eeecd8bed9","hash":"3bb5032d1444f2695c8c3152e9c5e1e54c63926c6c4798b5f4e1f36d08a485bd"}],"energy":{"passes":2,"tokens_in":27620,"tokens_out":3695,"tokens_total":31315,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"3bb5032d1444f2695c8c3152e9c5e1e54c63926c6c4798b5f4e1f36d08a485bd"},"posted_at":"2026-06-29T21:33:21.639Z","created_at":"2026-06-29T21:33:21.639Z","updated_at":"2026-07-17T02:42:02.778Z","machine":{"shape":"article.machine/v1","slug":"ss-31-frozen-shoulder","kind":"article","read":{"human":"https://miscsubjects.com/a/ss-31-frozen-shoulder","json":"https://miscsubjects.com/api/articles/ss-31-frozen-shoulder","bundle":"https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":6,"sources":5,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=ss-31-frozen-shoulder","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ss-31-frozen-shoulder\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ss-31-frozen-shoulder\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"ss-31-frozen-shoulder\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/ss-31-frozen-shoulder | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/ss-31-frozen-shoulder","json":"/api/articles/ss-31-frozen-shoulder","markdown":"/api/articles/ss-31-frozen-shoulder/bundle?format=markdown","skill":"/api/articles/ss-31-frozen-shoulder/skill","topology":"/api/articles/ss-31-frozen-shoulder/topology","versions":"/api/articles/ss-31-frozen-shoulder/revisions","invocations":"/api/articles/ss-31-frozen-shoulder/invocations"},"editorial_review":null,"editorial_audit":{"slug":"ss-31-frozen-shoulder","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"aa9f7d6175d959dd74d094389c71dcc02e4d695e3adeff524a756c6af10522c3","object":{"object_type":"article-object","identity":{"id":"article:ss-31-frozen-shoulder","slug":"ss-31-frozen-shoulder","title":"SS-31 (Elamipretide) for Frozen Shoulder: Mitochondrial Evidence Review"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/ss-31-frozen-shoulder","role":"explain","audience":"human"},"skill":{"route":"/api/articles/ss-31-frozen-shoulder/skill","role":"direct behavior","audience":"model","content":"---\nname: ss-31-frozen-shoulder\ndescription: Apply the SS-31 (Elamipretide) for Frozen Shoulder: Mitochondrial Evidence Review article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# SS-31 (Elamipretide) for Frozen Shoulder: Mitochondrial Evidence Review\n\nThis Skill is the behavioral expression of [the canonical article](/a/ss-31-frozen-shoulder). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/ss-31-frozen-shoulder.\n- Read claims and relationships at /api/articles/ss-31-frozen-shoulder/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down if you have Frozen shoulder Frozen shoulder, also called adhesive capsulitis, involves the shoulder joint capsule becoming inflamed and thickened. Adhesions form inside the capsule. This leads to progressive stiffness a\n\n## Representations\n\n- Human: /a/ss-31-frozen-shoulder\n- JSON: /api/articles/ss-31-frozen-shoulder\n- Relationships: /api/articles/ss-31-frozen-shoulder/topology\n- History: /api/articles/ss-31-frozen-shoulder/revisions\n"},"json":{"route":"/api/articles/ss-31-frozen-shoulder","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/ss-31-frozen-shoulder/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","ss","31","frozen","shoulder"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/ss-31-frozen-shoulder/invocations?status=success","failure_events":"/api/articles/ss-31-frozen-shoulder/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"ss-31-frozen-shoulder","title":"SS-31 (Elamipretide) for Frozen Shoulder: Mitochondrial Evidence Review","body":"## What's breaking down if you have Frozen shoulder\n\nFrozen shoulder, also called adhesive capsulitis, involves the shoulder joint capsule becoming inflamed and thickened. Adhesions form inside the capsule. This leads to progressive stiffness and pain that limits range of motion.\n\nThe condition often develops in stages. An initial painful phase features inflammation. A freezing phase brings increasing stiffness. A frozen phase shows restricted movement with less pain. A thawing phase sees gradual improvement over months to years.\n\nDegeneration layers include chronic low-grade inflammation, excessive collagen deposition causing fibrosis, reduced blood flow to the capsule, and possible mitochondrial stress in shoulder muscles and connective tissue cells. If mitochondrial function declines, cells produce less ATP and more reactive oxygen species. This can slow tissue repair and prolong the inflammatory state. The capsule and surrounding muscles then stay in a cycle where breakdown outruns natural repair.\n\nNo weight-loss drugs appear in scope here. Mechanical load reduction is not a primary factor for the shoulder in the same way it is for the spine, though overall inflammation reduction could indirectly ease joint stress.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about **Frozen shoulder** — what breaks down matters before any compound name.\n2. **Therefore for you:** If mitochondrial dysfunction is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\n\nSS-31 binds to cardiolipin in the inner mitochondrial membrane. This stabilizes the membrane, reduces excess reactive oxygen species, and supports ATP production. In a shoulder capsule or muscle cell under inflammatory stress, better mitochondrial output could supply energy for repair processes instead of letting oxidative damage accumulate.\n\nIf your frozen shoulder shows persistent inflammation or slow healing after months, the mitochondrial layer may contribute. SS-31 focuses on that layer by protecting mitochondria rather than broadly suppressing immune signals or numbing nerves.\n\n## How these fit together\n\nSingle-compound focus. SS-31 (Elamipretide) targets the mitochondrial layer. If your condition profile includes a multi-peptide stack in other contexts, siblings would address other layers such as direct anti-fibrotic or vascular support. Here the emphasis stays on mitochondrial bioenergetics as one potential repair pathway.\n\n## What the evidence actually shows\n\nNo published human trials test SS-31 specifically in frozen shoulder or adhesive capsulitis (preclinical tier for condition match). Clinical trials of SS-31 exist in other mitochondrial or inflammatory conditions.\n\nPreclinical studies show SS-31 protects cartilage after impact injury in bovine knee models and reduces osteoarthritis symptoms in guinea pig models via radiographic and histologic scores (preclinical). One murine tendinopathy model examined SS-31 in supraspinatus tendon (preclinical). Neuroinflammation and kidney injury models demonstrate reduced oxidative stress and preserved ATP (preclinical).\n\nHuman data come from trials in primary mitochondrial myopathy, heart failure, and Barth syndrome. A phase 1/2 trial in primary mitochondrial myopathy reported dose-dependent exercise improvements (human). Barth syndrome received FDA approval in 2025 based on functional gains (human). No shoulder-specific outcomes appear in those trials.\n\nAnecdotal reports on forums mention SS-31 use for general energy or other joint issues but lack controlled data on frozen shoulder resolution (anecdotal).\n\n## What scientists say\n\nResearchers describe SS-31 as a mitochondria-targeted tetrapeptide that improves bioenergetics without affecting healthy mitochondria. Publications note benefits in models of oxidative stress and fibrosis (mechanistic). They emphasize the need for more targeted human studies in musculoskeletal conditions (speculative for frozen shoulder).\n\n## What people say on Reddit\n\nForum users discuss SS-31 in broader peptide stacks for recovery or energy. Isolated mentions link other peptides to frozen shoulder improvement. Direct SS-31 experiences for this condition remain rare and uncontrolled (anecdotal). Some report subjective energy gains; others note no clear change or mild side effects.\n\n## What people say on X\n\nPosts reference SS-31 clinical progress in heart failure and mitochondrial disorders. One user with a shoulder injury mentioned ongoing SS-31 use alongside other approaches but provided no outcome details (anecdotal). Discussions focus on mitochondrial support in low-vascular tissues rather than frozen shoulder specifically.\n\n## What we do not know\n\nDirect evidence linking SS-31 to frozen shoulder capsule repair or symptom resolution is absent. Human trials have not measured shoulder range of motion, pain scores, or imaging changes with this peptide. Long-term effects on fibrosis or adhesions remain unstudied. Optimal timing relative to disease stage is unknown.\n\n## Safety and limits\n\nIn published trials, SS-31 was generally well tolerated. Common reports include mild injection site reactions. Serious adverse events appear infrequent across mitochondrial disease studies (human). It remains investigational outside approved rare-disease uses. Quality and sourcing vary widely for non-clinical material. No data confirm safety or efficacy when combined with physical therapy or other interventions for frozen shoulder.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/ss-31-frozen-shoulder/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No published human trials test SS-31 in frozen shoulder or adhesive capsulitis.","section":"What the evidence actually shows","tier":"preclinical","source_ids":[],"source_status":"unsourced","why_material":"Establishes the direct evidence gap for this specific condition.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"SS-31 protects bovine knee cartilage from impact injury in ex vivo models.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["web:16"],"source_status":"sourced","why_material":"Shows mitochondrial protection in joint tissue relevant to shoulder capsule stress.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"SS-31 reduced osteoarthritis symptoms in guinea pig models per radiographic and histologic scores.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["web:17"],"source_status":"sourced","why_material":"Demonstrates anti-degenerative effects in a joint model.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Phase 1/2 human trial of SS-31 in primary mitochondrial myopathy showed dose-dependent exercise improvements.","section":"What the evidence actually shows","tier":"human","source_ids":["web:11"],"source_status":"sourced","why_material":"Provides the strongest human functional data available.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"SS-31 received FDA approval for Barth syndrome in 2025 based on functional gains.","section":"What the evidence actually shows","tier":"human","source_ids":["web:3"],"source_status":"sourced","why_material":"Confirms regulatory recognition of mitochondrial benefit in a rare disease.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c6","text":"SS-31 binds cardiolipin to stabilize mitochondria and reduce ROS while supporting ATP.","section":"Why SS-31 (Elamipretide) might help you","tier":"mechanistic","source_ids":["web:14"],"source_status":"sourced","why_material":"Explains the repair-focused mechanism for the mitochondrial layer.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"web:3","type":"news","url":"https://www.fightaging.org/archives/2025/10/fda-approval-for-mitochondrial-therapeutic-elamipretide-formerly-ss-31/","title":"FDA Approval for Mitochondrial Therapeutic Elamipretide, Formerly SS-31","quote":"The recent FDA approval of elamipretide is for the treatment of a rare disease...","summary":"Reports 2025 FDA approval for Barth syndrome.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:56:01.675Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"0347420b479319c80d3046ab78579e86ccc25f867916838abcd8e95027a8e166"},{"id":"web:11","type":"pubmed","url":"https://www.neurology.org/doi/10.1212/WNL.0000000000005255","title":"Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy","quote":"a dose-dependent improvement in exercise performance was observed","summary":"Human trial results in PMM.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:56:01.675Z","link_status":"ok","quote_status":"unverified","prev":"0347420b479319c80d3046ab78579e86ccc25f867916838abcd8e95027a8e166","hash":"6451b9ec4e68274e0b9d7e1f25f7c1fd01ab8581432d39c0a444eb8d82dc91cf"},{"id":"web:16","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/SS-31-Cognitive-Vitality-For-Researchers.pdf","title":"SS-31 Cognitive Vitality For Researchers","quote":"SS-31 treatment immediately post-impact... resulted in chondrocyte viability similar to that of uninjured controls","summary":"Preclinical cartilage protection data.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:56:01.675Z","link_status":"ok","quote_status":"unverified","prev":"6451b9ec4e68274e0b9d7e1f25f7c1fd01ab8581432d39c0a444eb8d82dc91cf","hash":"ff6b364eae5703d46dcb507197ee42ee9bf09a28ab40ea445274f0f5d7835e71"},{"id":"web:17","type":"other","url":"https://www.ors.org/wp-content/uploads/AM24/2529.pdf","title":"Therapeutic Efficacy of mitoprotective SS-31 peptide in Osteoarthritis","quote":"significant reduction in cartilage damage and OA symptoms","summary":"Guinea pig OA model results.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:56:01.675Z","link_status":"ok","quote_status":"unverified","prev":"ff6b364eae5703d46dcb507197ee42ee9bf09a28ab40ea445274f0f5d7835e71","hash":"2740d9b97993e514ca54dd140fce8c8cf317c8b806b8cf52c5b4a282afba304e"},{"id":"web:14","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9192202/","title":"SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Injury","quote":"SS-31... decreases mitochondrial reactive oxygen species production and prevents mitochondrial depolarization","summary":"Mechanism details on ROS and mitochondria.","claim_ids":["c6"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:56:01.675Z","link_status":"ok","quote_status":"unverified","prev":"2740d9b97993e514ca54dd140fce8c8cf317c8b806b8cf52c5b4a282afba304e","hash":"7ebc2b63807ec666e1483243b0abbfdbb2eae2b28b7eac50011b2ffd61f3dfeb"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:56:02.397Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"SS-31 (Elamipretide) for Frozen Shoulder: Mitochondrial Evidence Review","register":"source_ledger","body":"## What's breaking down if you have Frozen shoulder\n\nFrozen shoulder, also called adhesive capsulitis, involves the shoulder joint capsule becoming inflamed and thickened. Adhesions form inside the capsule. This leads to progressive stiffness and pain that limits range of motion.\n\nThe condition often develops in stages. An initial painful phase features inflammation. A freezing phase brings increasing stiffness. A frozen phase shows restricted movement with less pain. A thawing phase sees gradual improvement over months to years.\n\nDegeneration layers include chronic low-grade inflammation, excessive collagen deposition causing fibrosis, reduced blood flow to the capsule, and possible mitochondrial stress in shoulder muscles and connective tissue cells. If mitochondrial function declines, cells produce less ATP and more reactive oxygen species. This can slow tissue repair and prolong the inflammatory state. The capsule and surrounding muscles then stay in a cycle where breakdown outruns natural repair.\n\nNo weight-loss drugs appear in scope here. Mechanical load reduction is not a primary factor for the shoulder in the same way it is for the spine, though overall inflammation reduction could indirectly ease joint stress.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about **Frozen shoulder** — what breaks down matters before any compound name.\n2. **Therefore for you:** If mitochondrial dysfunction is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\n\nSS-31 binds to cardiolipin in the inner mitochondrial membrane. This stabilizes the membrane, reduces excess reactive oxygen species, and supports ATP production. In a shoulder capsule or muscle cell under inflammatory stress, better mitochondrial output could supply energy for repair processes instead of letting oxidative damage accumulate.\n\nIf your frozen shoulder shows persistent inflammation or slow healing after months, the mitochondrial layer may contribute. SS-31 focuses on that layer by protecting mitochondria rather than broadly suppressing immune signals or numbing nerves.\n\n## How these fit together\n\nSingle-compound focus. SS-31 (Elamipretide) targets the mitochondrial layer. If your condition profile includes a multi-peptide stack in other contexts, siblings would address other layers such as direct anti-fibrotic or vascular support. Here the emphasis stays on mitochondrial bioenergetics as one potential repair pathway.\n\n## What the evidence actually shows\n\nNo published human trials test SS-31 specifically in frozen shoulder or adhesive capsulitis (preclinical tier for condition match). Clinical trials of SS-31 exist in other mitochondrial or inflammatory conditions.\n\nPreclinical studies show SS-31 protects cartilage after impact injury in bovine knee models and reduces osteoarthritis symptoms in guinea pig models via radiographic and histologic scores (preclinical). One murine tendinopathy model examined SS-31 in supraspinatus tendon (preclinical). Neuroinflammation and kidney injury models demonstrate reduced oxidative stress and preserved ATP (preclinical).\n\nHuman data come from trials in primary mitochondrial myopathy, heart failure, and Barth syndrome. A phase 1/2 trial in primary mitochondrial myopathy reported dose-dependent exercise improvements (human). Barth syndrome received FDA approval in 2025 based on functional gains (human). No shoulder-specific outcomes appear in those trials.\n\nAnecdotal reports on forums mention SS-31 use for general energy or other joint issues but lack controlled data on frozen shoulder resolution (anecdotal).\n\n## What scientists say\n\nResearchers describe SS-31 as a mitochondria-targeted tetrapeptide that improves bioenergetics without affecting healthy mitochondria. Publications note benefits in models of oxidative stress and fibrosis (mechanistic). They emphasize the need for more targeted human studies in musculoskeletal conditions (speculative for frozen shoulder).\n\n## What people say on Reddit\n\nForum users discuss SS-31 in broader peptide stacks for recovery or energy. Isolated mentions link other peptides to frozen shoulder improvement. Direct SS-31 experiences for this condition remain rare and uncontrolled (anecdotal). Some report subjective energy gains; others note no clear change or mild side effects.\n\n## What people say on X\n\nPosts reference SS-31 clinical progress in heart failure and mitochondrial disorders. One user with a shoulder injury mentioned ongoing SS-31 use alongside other approaches but provided no outcome details (anecdotal). Discussions focus on mitochondrial support in low-vascular tissues rather than frozen shoulder specifically.\n\n## What we do not know\n\nDirect evidence linking SS-31 to frozen shoulder capsule repair or symptom resolution is absent. Human trials have not measured shoulder range of motion, pain scores, or imaging changes with this peptide. Long-term effects on fibrosis or adhesions remain unstudied. Optimal timing relative to disease stage is unknown.\n\n## Safety and limits\n\nIn published trials, SS-31 was generally well tolerated. Common reports include mild injection site reactions. Serious adverse events appear infrequent across mitochondrial disease studies (human). It remains investigational outside approved rare-disease uses. Quality and sourcing vary widely for non-clinical material. No data confirm safety or efficacy when combined with physical therapy or other interventions for frozen shoulder.","claims":[{"id":"c1","text":"No published human trials test SS-31 in frozen shoulder or adhesive capsulitis.","section":"What the evidence actually shows","tier":"preclinical","source_ids":[],"source_status":"unsourced","why_material":"Establishes the direct evidence gap for this specific condition.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"SS-31 protects bovine knee cartilage from impact injury in ex vivo models.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["web:16"],"source_status":"sourced","why_material":"Shows mitochondrial protection in joint tissue relevant to shoulder capsule stress.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"SS-31 reduced osteoarthritis symptoms in guinea pig models per radiographic and histologic scores.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["web:17"],"source_status":"sourced","why_material":"Demonstrates anti-degenerative effects in a joint model.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Phase 1/2 human trial of SS-31 in primary mitochondrial myopathy showed dose-dependent exercise improvements.","section":"What the evidence actually shows","tier":"human","source_ids":["web:11"],"source_status":"sourced","why_material":"Provides the strongest human functional data available.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"SS-31 received FDA approval for Barth syndrome in 2025 based on functional gains.","section":"What the evidence actually shows","tier":"human","source_ids":["web:3"],"source_status":"sourced","why_material":"Confirms regulatory recognition of mitochondrial benefit in a rare disease.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c6","text":"SS-31 binds cardiolipin to stabilize mitochondria and reduce ROS while supporting ATP.","section":"Why SS-31 (Elamipretide) might help you","tier":"mechanistic","source_ids":["web:14"],"source_status":"sourced","why_material":"Explains the repair-focused mechanism for the mitochondrial layer.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:56:01.972Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"web:3","type":"news","url":"https://www.fightaging.org/archives/2025/10/fda-approval-for-mitochondrial-therapeutic-elamipretide-formerly-ss-31/","title":"FDA Approval for Mitochondrial Therapeutic Elamipretide, Formerly SS-31","quote":"The recent FDA approval of elamipretide is for the treatment of a rare disease...","link_status":"ok","quote_status":"unverified"},{"id":"web:11","type":"pubmed","url":"https://www.neurology.org/doi/10.1212/WNL.0000000000005255","title":"Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy","quote":"a dose-dependent improvement in exercise performance was observed","link_status":"ok","quote_status":"unverified"},{"id":"web:16","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/SS-31-Cognitive-Vitality-For-Researchers.pdf","title":"SS-31 Cognitive Vitality For Researchers","quote":"SS-31 treatment immediately post-impact... resulted in chondrocyte viability similar to that of uninjured controls","link_status":"ok","quote_status":"unverified"},{"id":"web:17","type":"other","url":"https://www.ors.org/wp-content/uploads/AM24/2529.pdf","title":"Therapeutic Efficacy of mitoprotective SS-31 peptide in Osteoarthritis","quote":"significant reduction in cartilage damage and OA symptoms","link_status":"ok","quote_status":"unverified"},{"id":"web:14","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9192202/","title":"SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Injury","quote":"SS-31... decreases mitochondrial reactive oxygen species production and prevents mitochondrial depolarization","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":27620,"tokens_out":3695,"cost":0.0437625,"prev_hash":"genesis","hash":"072b4be2a30b7750b29530bc6555c25d193b80302f9f411598f47278121f0a24"}],"provenance":[{"ts":"2026-06-29T23:56:02.397Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Ss 31 for Frozen Shoulder\nSlug: ss-31-frozen-shoulder\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Frozen shoulder\",\"condition_key\":\"frozen-shoulder\",\"primary_peptide\":\"ss-31\",\"peptides_in_scope\":[{\"id\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\"}],\"drugs_in_scope\":[],\"weight_sensitive\":true,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Frozen shoulder\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\",\"section_title\":\"Why SS-31 (Elamipretide) might help you\",\"layer\":\"mitochondrial\",\"steps\":[\"You are reading about **Frozen shoulder** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Frozen shoulder** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **SS-31 (Elamipretide)** → mitochondrial\",\"section_headings\":[\"What's breaking down if you have Frozen shoulder\",","response":"{\n  \"slug\": \"ss-31-frozen-shoulder\",\n  \"title\": \"SS-31 (Elamipretide) for Frozen Shoulder: Mitochondrial Evidence Review\",\n  \"body\": \"## What's breaking down if you have Frozen shoulder\\n\\nFrozen shoulder, also called adhesive capsulitis, involves the shoulder joint capsule becoming inflamed and thickened. Adhesions form inside the capsule. This leads to progressive stiffness and pain that limits range of motion.\\n\\nThe condition often develops in stages. An initial painful phase features inflammation. A freezing phase brings increasing stiffness. A frozen phase shows restricted movement with less pain. A thawing phase sees gradual improvement over months to years.\\n\\nDegeneration layers include chronic low-grade inflammation, excessive collagen deposition causing fibrosis, reduced blood flow to the capsule, and possible mitochondrial stress in shoulder muscles and connective tissue cells. If mitochondrial function declines, cells produce less ATP and more reactive oxygen species. This can slow tissue repair and prolong the inflammatory state. The capsule and surrounding muscles then stay in a cycle where breakdown outruns natural repair.\\n\\nNo weight-loss drugs appear in scope here. Mechanical load reduction is not a primary factor for the shoulder in the same way it is for the spine, though overall inflammation reduction could indirectly ease joint stress.\\n\\n## Why SS-31 (Elamipretide) might help you\\n\\n1. You are reading about **Frozen shoulder** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If mitochondrial dysfunction is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nSS-31 binds to cardiolipin in the inner mitochondrial membrane. This stabilizes the membrane, reduces excess reactive oxygen species, and supports ATP production. In a shoulder capsule or muscle cell under inflammatory stress, better mitochondrial output could supply energy for repair proc","tokens_in":27620,"tokens_out":3695,"cost":0,"prev":"genesis","hash":"d8e93df3e14938152ea079fb8b6c3a4629605ffd5cccac963e0288eeecd8bed9"},{"ts":"2026-07-17T02:42:02.778Z","model":"owner","action":"voxel_divide","prompt":"","input":"ss-31-frozen-shoulder","response":"26 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d8e93df3e14938152ea079fb8b6c3a4629605ffd5cccac963e0288eeecd8bed9","hash":"3bb5032d1444f2695c8c3152e9c5e1e54c63926c6c4798b5f4e1f36d08a485bd"}],"energy":{"passes":2,"tokens_in":27620,"tokens_out":3695,"tokens_total":31315,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"3bb5032d1444f2695c8c3152e9c5e1e54c63926c6c4798b5f4e1f36d08a485bd"},"posted_at":"2026-06-29T21:33:21.639Z","created_at":"2026-06-29T21:33:21.639Z","updated_at":"2026-07-17T02:42:02.778Z","machine":{"shape":"article.machine/v1","slug":"ss-31-frozen-shoulder","kind":"article","read":{"human":"https://miscsubjects.com/a/ss-31-frozen-shoulder","json":"https://miscsubjects.com/api/articles/ss-31-frozen-shoulder","bundle":"https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":6,"sources":5,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=ss-31-frozen-shoulder","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ss-31-frozen-shoulder\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ss-31-frozen-shoulder\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"ss-31-frozen-shoulder\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/ss-31-frozen-shoulder | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/ss-31-frozen-shoulder","json":"/api/articles/ss-31-frozen-shoulder","markdown":"/api/articles/ss-31-frozen-shoulder/bundle?format=markdown","skill":"/api/articles/ss-31-frozen-shoulder/skill","topology":"/api/articles/ss-31-frozen-shoulder/topology","versions":"/api/articles/ss-31-frozen-shoulder/revisions","invocations":"/api/articles/ss-31-frozen-shoulder/invocations"},"editorial_review":null,"editorial_audit":{"slug":"ss-31-frozen-shoulder","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"aa9f7d6175d959dd74d094389c71dcc02e4d695e3adeff524a756c6af10522c3"}}}